Skip to content

FIGS FIGS Marketing and selling

Marketing and selling at other companies

PBH
Prestige Consumer HealthcarePBH

Other financials

Income statement

See full
Revenue$159.9M+28.0%
Gross profit$108.3M+28.2%
Operating income$4.5M+2,225%
Net income$6.3M+6,265%
EPS (diluted)$0.03

Balance sheet

See full
Cash & equivalents$74.3M-17.4%
Total debt$60.6M+18.1%
Total equity$430.6M+12.9%
Total assets$563.4M+7.9%

Cash flow

See full
Operating cash flow-$3.2M-135%
CapEx$2.4M+85.0%
Free cash flow-$5.6M-171%

Valuation

See full
Market cap$1.97B+229%

Profitability

See full
Gross margin66.6%-0.7pp
Operating margin6.4%+6.1pp
Net margin6.1%+5.9pp
FCF margin5.9%-4.9pp

Returns & leverage

See full
Return on equity10%+9.7pp
Debt / equity0.1×0.0×
Current ratio5.4×+1.4×

Where this comes from

Reported directly by FIGS in its filing.

Tagged under the XBRL concept us-gaap:AccruedMarketingCostsCurrent.

The official record: FIGS’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about FIGS's marketing and selling.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FIGS's marketing and selling?
FIGS (FIGS) reported marketing and selling of $6.35M in Q1 2026.
How has FIGS's marketing and selling changed year-over-year?
FIGS's marketing and selling increased by 15.5% year-over-year, from $5.5M to $6.35M.
What is the long-term trend for FIGS's marketing and selling?
Over 4 years (2021 to 2025), FIGS's marketing and selling has grown at a 44.9% compound annual growth rate (CAGR), from $923K to $4.06M.